日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models.

内源性 CD28 驱动 CAR T 细胞在骨髓瘤和淋巴瘤模型中的持续活性。

Lieberman Mackenzie M, Tong Jason H, Odukwe Nkechi U, Chavel Colin A, Bishara Gina G, Crasti Kimberly M, Herr Megan M, Goala Payal, Purdon Terence J, Burchett Rebecca, Gillard Bryan M, Brackett Craig M, Tario Joseph D, Rosario Spencer R, McGray Aj Robert, Bramson Jonathan L, Davila Marco L, Brentjens Renier J, Malek Ehsan, Lee Kelvin P, Olejniczak Scott H

Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma

在嵌合抗原受体T细胞时代,维持较高干细胞采集阈值治疗多发性骨髓瘤的成本效益分析

Malek, Ehsan; Betts, Brian; Herr, Megan; Davila, Marco; Holtan, Shernan; Driscoll, James J; Yu, Han

Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide

本研究对接受PVX-410疫苗(靶向XBP1/CD138/CS1抗原)和西他诺司他(一种组蛋白去乙酰化酶抑制剂,HDACi)联合或不联合来那度胺治疗的冒烟型多发性骨髓瘤患者进行了Ib期临床试验,并分析了接受西他诺司他治疗的冒烟型多发性骨髓瘤患者的免疫特征。

Cirstea, Diana; Shome, Rajib; Samur, Mehmet; Talluri, Srikanth; Connolly, Joseph J; Wright, Alexandra Jean; Duvallet, Emilie; Joyce, Amanda N R; Lively, Kathleen; Basinsky, Gina; Yee, Andrew J; Chase, Cristiana Costa; Malek, Ehsan; Niesvizky, Ruben; Richardson, Paul G; Raje, Noopur S

Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401

更正:树突状细胞/骨髓瘤融合疫苗联合来那度胺维持治疗多发性骨髓瘤一线自体造血干细胞移植后的随机II期试验:BMT CTN 1401

Chung, David J; Shah, Nina; Wu, Juan; Logan, Brent; Bisharat, Lina; Callander, Natalie; Cheloni, Giulia; Anderson, Kenneth; Chodon, Thinle; Dhakal, Binod; Devine, Steve; Dutt, Poorvi Somaiya; Efebera, Yvonne; Geller, Nancy; Ghiasuddin, Haider; Hematti, Peiman; Holmberg, Leona; Howard, Alan; Johnson, Bryon; Karagkouni, Dimitra; Lazarus, Hillard M; Malek, Ehsan; McCarthy, Philip; McKenna, David; Mendizabal, Adam; Nooka, Ajay; Munshi, Nikhil; O'Donnell, Lynn; Patel, Krina; Rapoport, Aaron P; Reese, Jane; Rosenblatt, Jacalyn; Soiffer, Robert; Stroopinsky, Dina; Uhl, Lynne; Vlachos, Ioannis S; Waller, Edmund K; Young, James W; Pasquini, Marcelo C; Avigan, David

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.

树突状细胞/骨髓瘤融合疫苗联合来那度胺维持治疗多发性骨髓瘤一线自体造血细胞移植的随机 II 期试验:BMT CTN 1401

Chung David J, Shah Nina, Wu Juan, Logan Brent, Bisharat Lina, Callander Natalie, Cheloni Giulia, Anderson Kenneth, Chodon Thinle, Dhakal Binod, Devine Steve, Somaiya Dutt Poorvi, Efebera Yvonne, Geller Nancy, Ghiasuddin Haider, Hematti Peiman, Holmberg Leona, Howard Alan, Johnson Bryon, Karagkouni Dimitra, Lazarus Hillard M, Malek Ehsan, McCarthy Philip, McKenna David, Mendizabal Adam, Nooka Ajay, Munshi Nikhil, O'Donnell Lynn, Rapoport Aaron P, Reese Jane, Rosenblatt Jacalyn, Soiffer Robert, Stroopinsky Dina, Uhl Lynne, Vlachos Ioannis S, Waller Edmund K, Young James W, Pasquini Marcelo C, Avigan David

Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma

揭示免疫逃逸机制,为多发性骨髓瘤的免疫治疗策略提供信息

Swamydas, Muthulekha; Murphy, Elena V; Ignatz-Hoover, James J; Malek, Ehsan; Driscoll, James J

Novel therapies emerging in oncology to target the TGF-β pathway

肿瘤学领域涌现出针对TGF-β通路的新疗法

Kim, Byung-Gyu; Malek, Ehsan; Choi, Sung Hee; Ignatz-Hoover, James J; Driscoll, James J

Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria

对于包括符合 mSMART 标准的患者在内的多发性骨髓瘤患者,储存的外周血干细胞用于自体挽救性移植的成本高昂且利用率低。

Ahmed, Nausheen; Li, Lucy; Rojas, Patricio; Covut, Fahrettin; Reese-Koc, Jane; Kolk, Merle; Malek, Ehsan; Metheny, Leland; O'Brien, Timothy; Caimi, Paolo; de Lima, Marcos; Cooper, Brenda W

African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States

与美国白人相比,携带t(11;14)易位的非裔美国人在接受自体造血干细胞移植治疗多发性骨髓瘤后,生存率更高。

Badar, Talha; Hari, Parameswaran; Dávila, Omar; Fraser, Raphael; Wirk, Baldeep; Dhakal, Binod; Freytes, Cesar O; Rodriguez Valdes, Cesar; Lee, Cindy; Vesole, David H; Malek, Ehsan; Hildebrandt, Gerhard C; Landau, Heather; Murthy, Hemant S; Lazarus, Hillard M; Berdeja, Jesus G; Meehan, Kenneth R; Solh, Melhem; Diaz, Miguel Angel; Kharfan-Dabaja, Mohamed A; Callander, Natalie S; Farhadfar, Nosha; Bashir, Qaiser; Kamble, Rammurti T; Vij, Ravi; Munker, Reinhold; Kyle, Robert A; Chhabra, Saurabh; Hashmi, Shahrukh; Ganguly, Siddhartha; Jagannath, Sundar; Nishihori, Taiga; Nieto, Yago; Kumar, Shaji; Shah, Nina; D'Souza, Anita

Influence of gut microbiome on multiple myeloma: friend or foe?

肠道微生物群对多发性骨髓瘤的影响:是敌是友?

Ahmed, Nausheen; Ghannoum, Mahmoud; Gallogly, Molly; de Lima, Marcos; Malek, Ehsan